1. Home
  2. BLLN vs POST Comparison

BLLN vs POST Comparison

Compare BLLN & POST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$104.82

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Logo Post Holdings Inc.

POST

Post Holdings Inc.

HOLD

Current Price

$75.38

Market Cap

5.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
POST
Founded
2016
1895
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
5.0B
IPO Year
2025
2011

Fundamental Metrics

Financial Performance
Metric
BLLN
POST
Price
$104.82
$75.38
Analyst Decision
Buy
Buy
Analyst Count
7
7
Target Price
$126.71
$124.50
AVG Volume (30 Days)
501.7K
842.5K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
103.40
N/A
EPS
0.48
4.59
Revenue
$305,112,000.00
$8,158,100,000.00
Revenue This Year
$46.29
$4.93
Revenue Next Year
$30.14
$0.47
P/E Ratio
$220.69
$16.64
Revenue Growth
99.97
2.97
52 Week Low
$61.96
$75.40
52 Week High
$150.44
$116.35

Technical Indicators

Market Signals
Indicator
BLLN
POST
Relative Strength Index (RSI) 53.45 32.74
Support Level $79.07 N/A
Resistance Level $108.50 $102.43
Average True Range (ATR) 5.08 2.09
MACD 1.86 -0.51
Stochastic Oscillator 64.44 0.00

Price Performance

Historical Comparison
BLLN
POST

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About POST Post Holdings Inc.

Post Holdings Inc. is a consumer packaged goods holding company with products sold through grocery, club, and drug stores, mass merchandisers, foodservice, food ingredient, and eCommerce. It operates through four reportable segments: Post Consumer Brands, focused on North American ready-to-eat cereal and granola, pet food, and nut butters; Weetabix, focused on U.K. ready-to-eat cereal, muesli, and protein-based shakes; Foodservice, focused on egg and potato products; and Refrigerated Retail, focused on side dish, egg, cheese, and sausage products. Products are sold across channels, including retailers, wholesalers, convenience stores, pet supply retailers, drug store customers, military and national restaurant chains, with revenues largely generated in the U.S.

Share on Social Networks: